| Characteristics and clinical significance of histological variants of bladder cancer M Moschini, D D'andrea, S Korn, Y Irmak, F Soria, E Compérat, SF Shariat Nature Reviews Urology 14 (11), 651-668, 2017 | 174 | 2017 |
| PSMA ligand PET/MRI for primary prostate cancer: staging performance and clinical impact B Grubmüller, P Baltzer, S Hartenbach, D D’Andrea, TH Helbich, ... Clinical Cancer Research 24 (24), 6300-6307, 2018 | 147 | 2018 |
| Prevalence and trends in kidney stone among adults in the USA: analyses of national health and nutrition examination survey 2007–2018 data M Abufaraj, T Xu, C Cao, T Waldhoer, C Seitz, D D’andrea, A Siyam, ... European urology focus 7 (6), 1468-1475, 2021 | 123 | 2021 |
| Response assessment using 68Ga-PSMA ligand PET in patients undergoing 177Lu-PSMA radioligand therapy for metastatic castration-resistant prostate cancer B Grubmüller, D Senn, G Kramer, P Baltzer, D D’Andrea, KH Grubmüller, ... European journal of nuclear medicine and molecular imaging 46, 1063-1072, 2019 | 122 | 2019 |
| An up-to-date catalog of available urinary biomarkers for the surveillance of non-muscle invasive bladder cancer F Soria, MJ Droller, Y Lotan, P Gontero, D D’Andrea, KM Gust, M Rouprêt, ... World journal of urology 36, 1981-1995, 2018 | 121 | 2018 |
| 68Ga-PSMA 11 ligand PET imaging in patients with biochemical recurrence after radical prostatectomy – diagnostic performance and impact on therapeutic … B Grubmüller, P Baltzer, D D’andrea, S Korn, AR Haug, M Hacker, ... European journal of nuclear medicine and molecular imaging 45, 235-242, 2018 | 111 | 2018 |
| Pseudoprogression and hyperprogression during immune checkpoint inhibitor therapy for urothelial and kidney cancer F Soria, AI Beleni, D D’Andrea, I Resch, KM Gust, P Gontero, SF Shariat World Journal of Urology 36, 1703-1709, 2018 | 81 | 2018 |
| External beam radiotherapy increases the risk of bladder cancer when compared with radical prostatectomy in patients affected by prostate cancer: a population-based analysis M Moschini, E Zaffuto, PI Karakiewicz, DD Andrea, B Foerster, M Abufaraj, ... European urology 75 (2), 319-328, 2019 | 80 | 2019 |
| Association of smoking status with recurrence, metastasis, and mortality among patients with localized prostate cancer undergoing prostatectomy or radiotherapy: a systematic … B Foerster, C Pozo, M Abufaraj, A Mari, S Kimura, D D’Andrea, H John, ... JAMA oncology 4 (7), 953-961, 2018 | 75 | 2018 |
| Endocavitary treatment for upper tract urothelial carcinoma: A meta-analysis of the current literature B Foerster, D D'Andrea, M Abufaraj, S Broenimann, PI Karakiewicz, ... Urologic Oncology: Seminars and Original Investigations 37 (7), 430-436, 2019 | 74 | 2019 |
| Diagnostic accuracy, clinical utility and influence on decision‐making of a methylation urine biomarker test in the surveillance of non‐muscle‐invasive bladder cancer D D'Andrea, F Soria, S Zehetmayer, KM Gust, S Korn, JA Witjes, ... BJU international 123 (6), 959-967, 2019 | 71 | 2019 |
| Reliability of serial prostate magnetic resonance imaging to detect prostate cancer progression during active surveillance: a systematic review and meta-analysis P Rajwa, B Pradere, F Quhal, K Mori, E Laukhtina, NA Huebner, ... European urology 80 (5), 549-563, 2021 | 68 | 2021 |
| A systematic review and meta‐analysis of the impact of lymphovascular invasion in bladder cancer transurethral resection specimens A Mari, S Kimura, B Foerster, M Abufaraj, D d'Andrea, M Hassler, ... BJU international 123 (1), 11-21, 2019 | 65 | 2019 |
| Differences in trends in the use of robot‐assisted and open radical cystectomy and changes over time in peri‐operative outcomes among selected centres in North America and … S Zamboni, F Soria, R Mathieu, E Xylinas, M Abufaraj, D DAndrea, ... BJU international 124 (4), 656-664, 2019 | 64 | 2019 |
| Response assessment using [68Ga]Ga‐PSMA ligand PET in patients undergoing systemic therapy for metastatic castration‐resistant prostate cancer B Grubmüller, S Rasul, P Baltzer, H Fajkovic, D D'Andrea, F Berndl, ... The Prostate 80 (1), 74-82, 2020 | 62 | 2020 |
| Impact of adjuvant chemotherapy in patients with adverse features and variant histology at radical cystectomy for muscle‐invasive carcinoma of the bladder: Does histologic … S Berg, D D’Andrea, MW Vetterlein, AP Cole, SA Fletcher, MJ Krimphove, ... Cancer 125 (9), 1449-1458, 2019 | 60 | 2019 |
| Surgical checklist impact on recurrence‐free survival of patients with non‐muscle‐invasive bladder cancer undergoing transurethral resection of bladder tumour R Suarez‐Ibarrola, F Soria, M Abufaraj, D D'Andrea, M Preto, KM Gust, ... BJU international 123 (4), 646-650, 2019 | 54 | 2019 |
| A systematic review and meta-analysis of lymphovascular invasion in patients treated with radical cystectomy for bladder cancer A Mari, S Kimura, B Foerster, M Abufaraj, D D'Andrea, KM Gust, ... Urologic oncology: seminars and original investigations 36 (6), 293-305, 2018 | 51 | 2018 |
| En bloc resection for nonmuscle invasive bladder cancer: review of the recent literature K Mori, D D’Andrea, DV Enikeev, S Egawa, SF Shariat Current Opinion in Urology 30 (1), 41-47, 2020 | 50 | 2020 |
| Lymphocyte‐to‐monocyte ratio and neutrophil‐to‐lymphocyte ratio as biomarkers for predicting lymph node metastasis and survival in patients treated with radical cystectomy D D'Andrea, M Moschini, KM Gust, M Abufaraj, M Özsoy, R Mathieu, ... Journal of surgical oncology 115 (4), 455-461, 2017 | 49 | 2017 |
Shahrokh F. Shariat, M.D.Department of Urology, Comprehensive Cancer Center, Medical University of Vienna and GeneralGeverifieerd e-mailadres voor meduniwien.ac.at
